Teva Pharmaceutical Industries Limited Cash Flow Quality Index
Teva Pharmaceutical Industries Limited cash flow quality index. Teva Pharmaceutical Industries Limited (TEV) has a Cash Flow Quality Index of -0.11x as of March 2026. Operating cash flow of €-40.00 Million is below net income of €369.00 Million, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is Teva Pharmaceutical Industries Limited to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Teva Pharmaceutical Industries Limited (2015–2025)
Cash flow quality index of Teva Pharmaceutical Industries Limited from 2015 to 2025. Historical Cash Flow Quality Index for Teva Pharmaceutical Industries Limited across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Teva Pharmaceutical Industries Limited (TEV) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Teva Pharmaceutical Industries Limited Cash Flow Quality Index by Year (2015–2025)
Teva Pharmaceutical Industries Limited cash flow quality index by year from 2015 to 2025. Year-by-year earnings quality comparison for Teva Pharmaceutical Industries Limited. For the full cash flow conversion analysis, see TEV operating cash flow.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.17x | €1.65 Billion | €1.41 Billion | ▼ -38.9% |
| 2021 | 1.91x | €798.00 Million | €417.00 Million | ▼ -83.8% |
| 2016 | 11.82x | €3.89 Billion | €329.00 Million | ▲ +238.8% |
| 2015 | 3.49x | €5.54 Billion | €1.59 Billion | — |